Singapore markets closed

Zimmer Biomet Holdings, Inc. (ZBH)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
120.73-2.20 (-1.79%)
As of 02:43PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 25.03B
Enterprise value 31.62B
Trailing P/E 31.28
Forward P/E 15.75
PEG Ratio (5 yr expected) 1.89
Price/sales (ttm)3.27
Price/book (mrq)2.02
Enterprise value/revenue 4.01
Enterprise value/EBITDA 15.57

Trading information

Stock price history

Beta (5Y monthly) 1.21
52-week change 3-17.52%
S&P500 52-week change 323.73%
52-week high 3180.36
52-week low 3119.55
50-day moving average 3140.59
200-day moving average 3154.90

Share statistics

Avg vol (3-month) 31.45M
Avg vol (10-day) 31.6M
Shares outstanding 5208.91M
Implied shares outstanding 6N/A
Float 8208.64M
% held by insiders 10.06%
% held by institutions 191.95%
Shares short (14 Nov 2021) 42.05M
Short ratio (14 Nov 2021) 41.39
Short % of float (14 Nov 2021) 40.98%
Short % of shares outstanding (14 Nov 2021) 40.98%
Shares short (prior month 14 Oct 2021) 42.53M

Dividends & splits

Forward annual dividend rate 40.96
Forward annual dividend yield 40.78%
Trailing annual dividend rate 30.96
Trailing annual dividend yield 30.78%
5-year average dividend yield 40.75
Payout ratio 424.43%
Dividend date 330 Jan 2022
Ex-dividend date 426 Dec 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin 10.39%
Operating margin (ttm)16.67%

Management effectiveness

Return on assets (ttm)3.42%
Return on equity (ttm)6.67%

Income statement

Revenue (ttm)7.88B
Revenue per share (ttm)37.85
Quarterly revenue growth (yoy)-0.30%
Gross profit (ttm)4.9B
EBITDA 2.38B
Net income avi to common (ttm)819.3M
Diluted EPS (ttm)3.91
Quarterly earnings growth (yoy)-40.00%

Balance sheet

Total cash (mrq)928.6M
Total cash per share (mrq)4.45
Total debt (mrq)7.52B
Total debt/equity (mrq)59.12
Current ratio (mrq)1.81
Book value per share (mrq)60.84

Cash flow statement

Operating cash flow (ttm)1.56B
Levered free cash flow (ttm)1.3B